-
Follow the Money: Cancer Platform Expansion, Wearable Device for Metabolic Health, More
Bio-IT World | Caris will expand their platforms, MI Cancer Seek and Caris Assure; Biolinq will bring the first autonomous intradermal glucose sensor to market; and more.
Apr 29, 2025
-
Advancing Precision Medicine with Ethical AI and Standardized Data
Bio-IT World | The integration of artificial intelligence (AI) into precision medicine is transforming healthcare by enabling more personalized treatment strategies. However, along with these advancements come significant ethical considerations. AI must be implemented such that it enhances, rather than replaces, the physician-patient relationship while maintaining patient autonomy, transparency, and explainability in clinical decision-making.
Apr 25, 2025
-
Tech Veteran Chris Dwan Challenges Life Sciences to Build Infrastructure, Businesses Strategically
Bio-IT World | After years of contributing to the Bio-IT World community as a speaker, awards program judge, and leading consultant, technology expert Chris Dwan took the plenary stage at the 2025 Bio-IT World Conference & Expo, sharing wisdom gleaned from over two decades of building computing infrastructures for the New York Genome Center, Broad Institute, and Sema4 and others.
Apr 23, 2025
-
AI in Drug Development: Promise and Pitfalls
Bio-IT World | An expert panel of technology and pharmaceutical executives convened at this month's Bio-IT World Venture, Innovation, and Partnering event to discuss the transformative potential of artificial intelligence in drug development—and the significant challenges that still lie ahead. Participants included Rory Kelleher of NVIDIA, Bill Fitzgerald from Google Cloud, Bill Mayo of Bristol-Myers Squibb, Anthony Philippakis of GV (formerly Google Ventures), and Becky Stevenson of HSBC, moderated by Jeremy Goldberg of Arsenal Capital Partners.
Apr 22, 2025
-
Insilico’s Alex Zhavoronkov Highlights Generative AI's Impact on Drug Discovery and Aging Research
Bio-IT World | At the Bio-IT World Conference & Expo earlier this month, Alex Zhavoronkov, CEO and founder of Insilico Medicine, shared the company's progress in leveraging generative AI to accelerate drug discovery, particularly focusing on aging research. Celebrating the company's 11th year, Zhavoronkov emphasized his singular mission: helping people live longer, healthier lives.
Apr 17, 2025
-
AI Continues to Make Strides on Therapeutics and Research Progress
Bio-IT World | During the final plenary keynote of this year’s Bio-IT World Conference & Expo, we heard from Tris Dyson, Challenge Works, and Jeffrey Rothstein, Johns Hopkins University; Robert Green, Harvard Medical School; and Justin Scheer, Johnson & Johnson Innovative Medicine. They all gave presentations that highlighted artificial intelligence (AI) and machine learning’s (ML) ever-growing roles in research and healthcare, as well as the impact they have on the future of patient treatment, drug development, and more.
Apr 16, 2025


